At week 52 the reduction in triglycerides with TAK-085 2 g ( -13.9 % ) was similar to that with EPA-E 1.8 g ( -12.1 % ) , whereas the reduction seen with TAK-085 4 g ( -25.5 % ) was greater than that with EPA-E 1.8 g , as assessed by point estimates and 95 % confidence intervals .